Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients
- 317 Downloads
The genes involved in DNA repair system play a crucial role in the protection against mutations. It has been hypothesized that functional deficiencies in highly conserved DNA repair processes resulting from polymorphic variation may increase genetic susceptibility to breast cancer (BC). The aim of the present study was to evaluate the association of genetic polymorphisms in 2 DNA repair genes, XPD (Asp312Asn) and XRCC1 (A399G), with BC susceptibility. We further investigated the potential combined effect of these DNA repair variants on BC risk. Both XPD (xeroderma pigmentosum group D) and XRCC1 (X-ray repair cross-complementing group 1) polymorphisms were characterized in 100 BC Egyptian females and 100 healthy women who had no history of any malignancy by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) method and PCR with confronting two-pair primers (PCR-CTPP), using DNA from peripheral blood in a case control study. Our results revealed that the frequencies of AA genotype of XPD codon 312 polymorphism were significantly higher in the BC patients than in the normal individuals (P ≤ 0.003), and did not observe any association between the XRCC1 Arg399Gln polymorphism and risk of developing BC. Also, no association between both XPD Asp312Asn and XRCC1 A399G polymorphisms and the clinical characteristics of disease. Finally, the combination of AA(XPD) + AG(XRCC1) were significantly associated with BC risk. Our results suggested that, XPD gene is an important candidate gene for susceptibility to BC. Also, gene–gene interaction between XPD(AA) + XRCC1(AG) polymorphism may be associated with increased risk of BC in Egyptian women.
KeywordsNucleotide excision repair Base excision repair Breast cancer XPD XRCC1
This study was funded with the support of academic research in Zagazig University Projects, Zagazig University. Postgraduate and Research Affairs.
- 2.Ibrahim AS et al (2002) Cancer profile in Gharbiah, Egypt: methodology and results. Ministry of Health and Population Egypt and Middle East Cancer Consortium, CairoGoogle Scholar
- 3.Elatar I (2001) Cancer registration NCI, Egypt, Cairo. National Cancer Institute, EgyptGoogle Scholar
- 7.Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, Serrano-Fernandez P, Gorski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, Kladny J, Bieniek A, Nagay L, Haus O, Grzybowska E, Wandzel P, Niepsuj S, Narod SA, Lubinski J (2006) XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat 98:209–215PubMedCrossRefGoogle Scholar
- 16.Breast AJCC (2002) Cancer staging manual. In: American Joint Committee on Cancer, 6th ed. Springer, New York, pp 171–180Google Scholar
- 26.Wang HC, Liu CS, Wang HC, Tsai RY, Tsai CW, Wang RF, Chen YS, Chiu CF, Bau DT, Huang CY (2010) Significant association of XPD Asp312Asn polymorphism with breast cancer in Taiwanese patients. Chin J Physiol 53 (prepublication ahead of print)Google Scholar
- 28.Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, Pharoah PD (2005) Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev 14:1828–1831PubMedCrossRefGoogle Scholar